
Treatment of Breast Cancer with Natural Products
- 1st Edition - June 7, 2024
- Imprint: Academic Press
- Authors: Yachana Mishra, Vijay Mishra
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 9 1 3 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 9 1 4 - 8
Treatment of Breast Cancer with Natural Based Products is designed to provide a wide spectrum of information and knowledge on phytotherapeutics in breast cancer treatment. With a… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteThis book presents a groundbreaking opportunity for both academia and industry to reshape contemporary medical and healthcare approaches. With a specific emphasis on various facets of phytoconstituents within the realm of oncology, this publication serves as a precious asset for researchers, as well as graduate and post-graduate students specializing in oncology, pharmaceutical sciences, biotechnology, and related biomedical fields.
- Outlines the anticancer mechanisms shown by phytoconstituents
- Provides scholarly insights into recent developments in phytotherapeutics
- Assesses the opportunities and challenges of biopolymer-based nanocarriers in cancer research
- Focuses on the diverse, cutting-edge techniques for the fabrication of nanocarriers for the drug delivery of anticancer bioactives
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- About the authors
- Preface
- Acknowledgments
- Chapter One. Breast cancer: An insight
- 1. Introduction
- 2. Epidemiology of breast cancer
- 3. Etiology of breast cancer
- 4. Risk factors for breast cancer
- 5. Types of breast cancer
- 6. Breast cancer screening
- 7. Available approaches to control breast cancer
- 8. Treatments for breast cancer
- 9. Drug delivery systems in the treatment of breast cancer
- 10. Drug targeting approaches in the treatment of breast cancer
- 11. Conclusion and future perspectives
- Chapter Two. Curcumin in breast cancer treatment
- 1. Introduction
- 2. Curcumin
- 3. Physicochemical properties of curcumin
- 4. Anticancer action mechanism of curcumin
- 5. Reported studies of curcumin
- 6. Delivery systems of curcumin
- 7. Toxicity profile of curcumin
- 8. Clinical trials of curcumin
- 9. Conclusion and future perspectives
- Chapter Three. Paclitaxel in breast cancer treatment
- 1. Introduction
- 2. Paclitaxel
- 3. Physical and chemical characteristics of paclitaxel
- 4. Anticancer action mechanism of paclitaxel
- 5. Delivery systems of paclitaxel
- 6. Toxicity profile of paclitaxel
- 7. Conclusion and future aspects
- Chapter Four. Quercetin in breast cancer treatment
- 1. Introduction
- 2. Quercetin
- 3. Physicochemical properties of quercetin
- 4. Anticancer mechanism of action of quercetin
- 5. Reported studies of quercetin
- 6. Delivery systems of quercetin
- 7. Toxicity profile of quercetin
- 8. Clinical trials on quercetin
- 9. Patents on quercetin
- 10. Conclusion and future prospects
- Chapter Five. Resveratrol in breast cancer treatment
- 1. Introduction
- 2. Resveratrol
- 3. Physiochemical properties of resveratrol
- 4. Anticancer action mechanism of resveratrol
- 5. Reported studies of resveratrol
- 6. Delivery systems of resveratrol
- 7. Toxicity profile of resveratrol
- 8. Clinical trials on resveratrol
- 9. Conclusion and future perspectives
- Chapter Six. Sulforaphane in breast cancer treatment
- 1. Introduction
- 2. Sulforaphane
- 3. Physical and chemical properties of sulforaphane
- 4. Anticancer action mechanism of sulforaphane
- 5. Reported studies of sulforaphane
- 6. Hydrogel delivery systems of sulforaphane
- 7. Toxicity profile of sulforaphane
- 8. Clinical trials on sulforaphane
- 9. Patents on sulforaphane
- 10. Conclusion and future directions
- Chapter Seven. Epigallocatechin-3-gallate in breast cancer treatment
- 1. Introduction
- 2. Epigallocatechin
- 3. Basic physicochemical properties of epigallocatechin
- 4. Anticancer action mechanism of epigallocatechin
- 5. Reported studies of epigallocatechin
- 6. Delivery systems of epigallocatechin
- 7. Toxicity profile of epigallocatechin
- 8. Clinical trials on epigallocatechin
- 9. Patents on epigallocatechin
- 10. Conclusion and future perspectives
- Chapter eight. Allicin in breast cancer treatment
- 1. Introduction
- 2. Allicin
- 3. Basic physicochemical properties of allicin
- 4. Anticancer action mechanism of allicin
- 5. Reported studies of allicin
- 6. Delivery systems of allicin
- 7. Toxicity profile of allicin
- 8. Conclusion and future perspectives
- Chapter Nine. Berberine in breast cancer treatment
- 1. Introduction
- 2. Berberine
- 3. Basic physicochemical properties of berberine
- 4. Anticancer mechanism of berberine
- 5. Reported studies of berberine
- 6. Delivery systems of berberine
- 7. Toxicity profile of berberine
- 8. Clinical trials on berberine
- 9. Patents on berberine
- 10. Conclusion and future perspectives
- Chapter Ten. Vinca alkaloids in breast cancer treatment
- 1. Introduction
- 2. Vinca alkaloids
- 3. Basic physicochemical properties of vinca alkaloids
- 4. Anticancer mechanism of action of vinca alkaloids
- 5. Delivery systems of vinca alkaloids
- 6. Toxicity profile of vinca alkaloids
- 7. Clinical trials on vinca alkaloids
- 8. Patents on vinca alkaloids
- 9. Conclusion and future perspectives
- Index
- Edition: 1
- Published: June 7, 2024
- Imprint: Academic Press
- No. of pages: 330
- Language: English
- Paperback ISBN: 9780443299131
- eBook ISBN: 9780443299148
YM
Yachana Mishra
Dr. Yachana Mishra, PhD, is an Associate Professor at the School of Bioengineering and Biosciences, Lovely Professional University, Phagwara (Punjab), India. She received her Ph.D. degree from Indian Grassland and Fodder Research Institute (IGFRI), Bundelkhand University, Jhansi (U.P.), India. Dr. Mishra has published more than 55 research and review articles in journals of high repute, 25 book chapters, 7 books, 4 Indian patents (Filed) and 5 Indian Copyrights (Granted). She has 15+ years of academic and research experience. She is a life member of different reputed organizations like Indian Science Congress Association, Kolkata (India), and the Society of Pharmaceutical Education and Research (SPER), India. She also serves as a reviewer of various journals of high repute. Her research areas include nanomedicine, cancer, diabetes, phytopharmaceuticals, and nanocarriers.
VM